
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5829006
[patent_doc_number] => 20060063742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Method of treatment for or protection against lymphedema'
[patent_app_type] => utility
[patent_app_number] => 10/945754
[patent_app_country] => US
[patent_app_date] => 2004-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3028
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063742.pdf
[firstpage_image] =>[orig_patent_app_number] => 10945754
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/945754 | Method of treatment for or protection against lymphedema | Sep 20, 2004 | Abandoned |
Array
(
[id] => 7013978
[patent_doc_number] => 20050066381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Regulation of cardiac contractility and heart failure propensity'
[patent_app_type] => utility
[patent_app_number] => 10/944375
[patent_app_country] => US
[patent_app_date] => 2004-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 24604
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20050066381.pdf
[firstpage_image] =>[orig_patent_app_number] => 10944375
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/944375 | Regulation of cardiac contractility and heart failure propensity | Sep 16, 2004 | Abandoned |
Array
(
[id] => 7034228
[patent_doc_number] => 20050032738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Method of treating cancer by conjunctive therapy with 2\'-haloemethylidene derivatives and a S-phase or M-phase specific antineoplastic agent'
[patent_app_type] => utility
[patent_app_number] => 10/943429
[patent_app_country] => US
[patent_app_date] => 2004-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4110
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032738.pdf
[firstpage_image] =>[orig_patent_app_number] => 10943429
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/943429 | Method of treating cancer by conjunctive therapy with 2'-haloemethylidene derivatives and a S-phase or M-phase specific antineoplastic agent | Sep 16, 2004 | Abandoned |
Array
(
[id] => 7216070
[patent_doc_number] => 20050054612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Delivery by labile hydrophobic modification of drugs'
[patent_app_type] => utility
[patent_app_number] => 10/929697
[patent_app_country] => US
[patent_app_date] => 2004-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12675
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054612.pdf
[firstpage_image] =>[orig_patent_app_number] => 10929697
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/929697 | Delivery by labile hydrophobic modification of drugs | Aug 29, 2004 | Abandoned |
Array
(
[id] => 6991507
[patent_doc_number] => 20050090544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Oxaliplatin formulations'
[patent_app_type] => utility
[patent_app_number] => 10/927279
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6726
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090544.pdf
[firstpage_image] =>[orig_patent_app_number] => 10927279
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/927279 | Oxaliplatin formulations | Aug 26, 2004 | Abandoned |
Array
(
[id] => 5902517
[patent_doc_number] => 20060045898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'Weather resistant granular slug, snail and insect bait'
[patent_app_type] => utility
[patent_app_number] => 10/928510
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3617
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20060045898.pdf
[firstpage_image] =>[orig_patent_app_number] => 10928510
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/928510 | Weather resistant granular slug, snail and insect bait | Aug 26, 2004 | Abandoned |
Array
(
[id] => 5590448
[patent_doc_number] => 20060039899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Animal nutritional product that increases weight gain and reduces diarrhea morbidity, mortality and severity by stimulation of natural immune response, nutritional support of immune function and supplemental nutricines and probiotics'
[patent_app_type] => utility
[patent_app_number] => 10/923313
[patent_app_country] => US
[patent_app_date] => 2004-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8293
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20060039899.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923313
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923313 | Animal nutritional product that increases weight gain and reduces diarrhea morbidity, mortality and severity by stimulation of natural immune response, nutritional support of immune function and supplemental nutricines and probiotics | Aug 22, 2004 | Abandoned |
Array
(
[id] => 7024968
[patent_doc_number] => 20050019362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Non-flammable aerosol insecticidal compositions'
[patent_app_type] => utility
[patent_app_number] => 10/920502
[patent_app_country] => US
[patent_app_date] => 2004-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2996
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019362.pdf
[firstpage_image] =>[orig_patent_app_number] => 10920502
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/920502 | Non-flammable aerosol insecticidal compositions | Aug 17, 2004 | Abandoned |
Array
(
[id] => 7145797
[patent_doc_number] => 20050119288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Dosing schedule for a novel anticancer agent'
[patent_app_type] => utility
[patent_app_number] => 10/919831
[patent_app_country] => US
[patent_app_date] => 2004-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16544
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20050119288.pdf
[firstpage_image] =>[orig_patent_app_number] => 10919831
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/919831 | Dosing schedule for a novel anticancer agent | Aug 16, 2004 | Abandoned |
Array
(
[id] => 7172507
[patent_doc_number] => 20050203082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Combination therapy with inhibitors of inducible nitric oxide synthase and alkylating agents'
[patent_app_type] => utility
[patent_app_number] => 10/918535
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57282
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203082.pdf
[firstpage_image] =>[orig_patent_app_number] => 10918535
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/918535 | Combination therapy with inhibitors of inducible nitric oxide synthase and alkylating agents | Aug 12, 2004 | Abandoned |
Array
(
[id] => 7435272
[patent_doc_number] => 20040266779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Use of c-kit inhibitors for the treatment of myeloma'
[patent_app_type] => new
[patent_app_number] => 10/489643
[patent_app_country] => US
[patent_app_date] => 2004-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6255
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266779.pdf
[firstpage_image] =>[orig_patent_app_number] => 10489643
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/489643 | Use of c-kit inhibitors for the treatment of myeloma | Aug 4, 2004 | Abandoned |
Array
(
[id] => 7010309
[patent_doc_number] => 20050064025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers'
[patent_app_type] => utility
[patent_app_number] => 10/909751
[patent_app_country] => US
[patent_app_date] => 2004-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12121
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20050064025.pdf
[firstpage_image] =>[orig_patent_app_number] => 10909751
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/909751 | Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers | Aug 1, 2004 | Issued |
Array
(
[id] => 6972394
[patent_doc_number] => 20050038104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Substitute benzothiophene compounds'
[patent_app_type] => utility
[patent_app_number] => 10/902562
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18120
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20050038104.pdf
[firstpage_image] =>[orig_patent_app_number] => 10902562
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/902562 | Substitute benzothiophene compounds | Jul 28, 2004 | Issued |
Array
(
[id] => 7156295
[patent_doc_number] => 20050026933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Use of a combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/900655
[patent_app_country] => US
[patent_app_date] => 2004-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5102
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026933.pdf
[firstpage_image] =>[orig_patent_app_number] => 10900655
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/900655 | Use of a combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer | Jul 27, 2004 | Abandoned |
Array
(
[id] => 7061683
[patent_doc_number] => 20050004045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Substances for use in treating psoriasis'
[patent_app_type] => utility
[patent_app_number] => 10/900740
[patent_app_country] => US
[patent_app_date] => 2004-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6299
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004045.pdf
[firstpage_image] =>[orig_patent_app_number] => 10900740
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/900740 | Substances for use in treating psoriasis | Jul 27, 2004 | Abandoned |
Array
(
[id] => 10831393
[patent_doc_number] => 08859562
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-14
[patent_title] => 'Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/555507
[patent_app_country] => US
[patent_app_date] => 2004-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 15
[patent_no_of_words] => 7326
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10555507
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555507 | Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer | Jul 22, 2004 | Issued |
Array
(
[id] => 314895
[patent_doc_number] => 07524865
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-28
[patent_title] => 'Methods and compositions for treating an ocular neovascular disease'
[patent_app_type] => utility
[patent_app_number] => 10/896780
[patent_app_country] => US
[patent_app_date] => 2004-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 8004
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524865.pdf
[firstpage_image] =>[orig_patent_app_number] => 10896780
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/896780 | Methods and compositions for treating an ocular neovascular disease | Jul 20, 2004 | Issued |
Array
(
[id] => 4459014
[patent_doc_number] => 07879365
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-01
[patent_title] => 'Zinc salt compositions for the prevention of dermal and mucosal irritation'
[patent_app_type] => utility
[patent_app_number] => 10/892034
[patent_app_country] => US
[patent_app_date] => 2004-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19945
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/879/07879365.pdf
[firstpage_image] =>[orig_patent_app_number] => 10892034
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/892034 | Zinc salt compositions for the prevention of dermal and mucosal irritation | Jul 14, 2004 | Issued |
Array
(
[id] => 7083929
[patent_doc_number] => 20050049309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Regulation of HIF protein levels via deubiquitination pathway'
[patent_app_type] => utility
[patent_app_number] => 10/890756
[patent_app_country] => US
[patent_app_date] => 2004-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9891
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20050049309.pdf
[firstpage_image] =>[orig_patent_app_number] => 10890756
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/890756 | Regulation of HIF protein levels via deubiquitination pathway | Jul 13, 2004 | Abandoned |
Array
(
[id] => 7127949
[patent_doc_number] => 20050059693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Heterocyclic thioester and ketone hair growth compositions and uses'
[patent_app_type] => utility
[patent_app_number] => 10/876785
[patent_app_country] => US
[patent_app_date] => 2004-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10204
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059693.pdf
[firstpage_image] =>[orig_patent_app_number] => 10876785
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/876785 | Heterocyclic thioester and ketone hair growth compositions and uses | Jun 27, 2004 | Abandoned |